Pyrimidine and thienopyrimidine derivatives have attracted a great deal of interest owing to their medicinal activities (1-4). Pyrimidine derivatives and heterocyclic annelated pyrimidines continue to attract great interest due to the wide variety of interesting biological activities observed for these compounds, such as anticancer (4), antiviral (5), antitumor (6), anti-inflammatory (7) and antimicrobial activities (8). Also, the rapid growth in the literature dealing with the synthesis and biological activity of the thienopyrimidine derivatives prompted us to synthesize new derivatives of fused pyrimidine, thienopyrimidine and thienopyridine derivatives. In our previous work (9, 10), we reported the behaviour of thienopyrimidine derivatives towards hydrazines, 1,3-diketones, a-haloketones and acids. As part of this work, here we report a new synthesis strategy for the preparation of functionalized thieno [2,3-d] 5-Methyl-6-phenyl-2-thioxothieno[2,3-d]pyrimidone derivative (2) reacted with hydrazonoyl chloride derivatives to afford triazolothienopyrimidones 4a-f. Also, acetone--1-(2-amino-5-isopropyl-thiophene-3-carbonitrile) (3) reacted with functional and bifunctional groups to yield the corresponding compounds 5-11. The new products showed anti-inflammatory, analgesic, and ulcerogenic activities comparable to that of indomethacin and acetylsalicylic acid, respectively.
solid produced was washed three times with 30 mL absolute ethanol and crystallized from an appropriate solvent. [2,3-d] [1, 2, 4] triazolo [4,3-a] pyrimidin-5-one (4a). -Compound 4a was obtained from 2 (2.74 g, 0.01 mol) and N-phenylbenzene-carbohydrazonoyl chloride (2.31 g, 0.01 mol) as white needles, and crystallized from dimethylformamide. [2,3-d] [1, 2, 4] triazolo- [4,3-a] pyrimidin--5-one (4b). -Compound 4b was obtained from 2 (2.74 g, 0.01 mol) and 2-oxo-N-(4-chlorophenyl)-propane hydrazonoyl chloride (1.96 g, 0.01 mol) as brown powder, and crystallized from dimethylformamide. [2,3-d] [1, 2, 4] triazolo- [4,3-a] pyrimidin-5-one (4c). -Compound 4c was obtained from 2 (2.74 g, 0.01 mol) and 2-oxo-N-(4--methoxy-phenyl)-propane hydrazonoyl chloride (1.91 g, 0.01 mol) as green powder, and crystallized from absolute ethanol. [2,3-d] [1, 2, 4] triazolo [4,3-a] pyrimidin--5-one (4d). -Product 4d was obtained from 2 (2.74 g, 0.01 mol) and 2-oxo-N-(4-nitrophenyl)-propane hydrazonoyl chloride (2.06 g, 0.01 mol) as pale red crystals, and crystallized from absolute ethanol. [2,3-d] [1, 2, 4] triazolo [4,3-a] pyrimidin-5-one-3-ethylcarboxylate (4e). -Compound 4e was obtained from 2 (2.74 g, 0.01 mol) and chloro-(phenylhydrazono)-ethyl acetate (2.27 g, 0.01 mol) as white powder, and crystallized from dimethylformamide. [2,3-d] [1, 2, 4] triazolo [4,3-a] pyrimidin-5-one-3-ethylcarboxylate (4f). -Compound 4f was obtained from 2 (2.74 g, 0.01 mol) and chloro-(4-tolylhydrazono)-ethyl acetate (2.41 g, 0.01 mol) as yellow powder, and crystallized from absolute ethanol/dioxane.
6-Methyl-1,3,7-triphenyl-thieno

3-Acetyl-1-(4-chlorophenyl)-7-phenyl-6-methyl-thieno
3-Acetyl-1-(4-methoxyphenyl)-7-phenyl-6-methyl-thieno
3-Acetyl-1-(4-nitrophenyl)-7-phenyl-6-methyl-thieno
1,7-Diphenyl-6-methyl-thieno
7-Phenyl-6-methyl-1-(4-tollyl)-thieno
Synthesis of 6-isopropyl-5-(2-oxo-propyl)-3H-thieno[2,3-d]pyrimidin-4-one (5a)
A mixture of compound 3 (2.22 g, 0.01 mol), formic acid (10 mL) and catalytic amount of concentrated hydrochloric acid was heated under reflux for 12 hours. The reaction mixture was allowed to cool to room temperature, poured into water (100 mL). The formed solid was collected by filtration, washed with absolute ethanol (20 mL), dried and crystallized from dimethylformamide.
Synthesis of 6-isopropyl-2-methyl-5-(2-oxo-propyl)-3H-thieno[2,3-d]pyrimidin-4-one (5b)
A mixture of 3 (2.22 g, 0.01 mol) and glacial acetic acid (30 mL) was stirred under reflux for 12 hours (under TLC analysis). The reaction mixture was allowed to cool to room temperature and was poured into water (100 mL). The solid thus-formed was collected by filtration, washed with etanol (20 mL), dried and crystallized from dimethylformamide.
Synthesis of 1-(6-isopropyl-2,4-dithioxo-1,2,3,4-tetrahydro-thieno[2,3-d]pyrimidin--5-yl)-propan-2-one (6)
A mixture of compound 3 (2.22 g, 0.01 mol) and carbon disulphide (excess 10 mL) was heated under reflux in absolute ethanolic potassium hydroxide solution for 12 hours. The reaction mixture was allowed to cool to 0°C for 3 hours, the deposited precipitate was filtered off, washed with water (20 mL), dried and crystallized from dioxane.
Synthesis of 1-(4-imino-6-isopropyl-2-thioxo-1,4-dihydro-2H-thieno[2,3-d][1,3]--thiazin-5-yl)-propan-2-one (7)
A mixture of compound 3 (2.22 g, 0.01 mol) and carbon disulphide (excess 10 mL) was heated under reflux on a waterbath (80°C) in 20 mL pyridine for 8 hours (under TLC control). The reaction mixture was allowed to cool to 0°C for 3 hours, the deposited precipitate was filtered off, washed with absolute ethanol (20 mL), dried and crystallized from dioxane.
Synthesis of 4-amino-6-isopropyl-5-(2-oxo-propyl)-1H-thieno[2,3-d]pyrimidin-(2-one or 2-thione) (8a,b). General procedure
A mixture of compound 3 (2.22 g, 0.01 mol) and urea or thiourea (0.01 mol) was heated at 180°C in a test tube on sand-bath for 4 hours. The mixture was allowed to cool to room temperature; the product was solidified by cooling and addition of absolute ethanol (50 mL). The precipitate thus-formed was collected by filtration and crystallized from an appropriate solvent. [2,3-d] pyrimidin-2-one (8a). -Compound 8a was obtained from 3 and urea (0.61 g, 0.01 mol), as dark brown crystals and crystallized from dimethylformamide. [2,3-d] pyrimidine-2-thione (8b). -Compound 8b was obtained from 3 and thiourea (0.77 g, 0.01 mol) as brown crystals and crystallized from dioxane.
4-Amino-6-isopropyl-5-(2-oxo-propyl)-1H-thieno
Synthesis of 4,6-diamino-2-isopropyl-3-(2-oxo-propyl)-thieno[2,3-b]pyridine-5-carbonitrile (9)
To a solution of 3 (2.22 g, 0.01 mol) in glacial acetic acid (50 mL), malononitrile (0.66 g, 0.01 mol) was added. The reaction mixture was stirred under reflux for 8 hours, cooled to room temperature, then poured into cold water (100 mL). The solid product was filtered off, washed with water, dried and crystallized from absolute ethanol. [2,3-b] pyridine--5-carbonitrile (10) A mixture of 3 (2.22 g, 0.01 mol) and ethylcyanoacetate (1.13 g, 0.01 mol) in dry dixane (50 mL) containing a catalytic amount of triethylamine was stirred under reflux for 8 hours. The reaction mixture was allowed to cool and poured into cold water (100 mL) and neutralized with acetic acid. The precipitate was filtered off, washed with water, dried and crystallized from dioxane.
Synthesis of 4-amino-6-hydroxy-2-isopropyl-3-(2-oxo-propyl)-thieno
Synthesis of N-[3-cyano-5-isopropyl-4-(2-oxo-propyl)-thiophen-2-yl]-formamidic acid ethyl ester (11a)
A mixture of compound 3 (2.22 g, 0.01 mol) and triethylorthoformate (2.96 g, 20 mmol) was stirred under reflux in acetic anhydride (30 mL) for 6 hours. The reaction mixture was allowed to cool to room temperature, poured into cold water (100 mL) and neutralized by ammonia solution. The deposited precipitate was collected by filtration, washed with water, dried and crystallized from absolute ethanol.
Synthesis of N-[3-cyano-5-isopropyl-4-(2-oxo-propyl)-thiophen-2-yl]-acetimidic acid ethyl ester (11b)
A mixture of compound 3 (2.22 g, 0.01 mol) and triethylorthoacetate (2.96 g, 20 mmol) was stirred under reflux in acetic anhydride (30 mL) for 6 hours. The reaction mixture was allowed to cool to room temperature, poured into cold water (100 mL) and neutralized by ammonia solution. The deposited precipitate was collected by filtration, washed with water, dried and crystallized from benzene.
Synthesis of N-[3-cyano-5-isopropyl-4-(2-oxo-propyl)-thiophen-2-yl]-formamidine (12)
A mixture of 11a (2.78 g, 0.01 mol) and ammonia solution (35%, 20 mL) was stirred under reflux in absolute ethanol (20 mL) for 8 hours. The reaction mixture was allowed to cool to room temperature, poured into cold water (100 mL) and neutrallized by diluted hydrochloric acid. The deposited white powder precipitate was collected by filtration, washed with water, dried and crystallized from absolute ethanol.
Synthesis of 1-(4-amino-6-isopropyl-thieno[2,3-d]pyrimidin-5-yl)-propan-2-one (13)
To a warmed absolute ethanolic sodium ethoxide solution [prepared by dissolving 0.23 g (0.01 mol) sodium metal in 50 mL absolute ethanol], compound 12 (2.49 g, 0.01 mol) was added. The mixture was stirred under reflux for 8 hours. The reaction mixture was allowed to cool to room temperature, poured into cold water (100 mL) and neutralized by acetic acid. The deposited precipitate was filtered off, dried and crystallized from benzene.
Synthesis of 1-(3-amino-4-imino-6-isopropyl-3,4-dihydro-thieno[2,3-d]pyrimidin-5-yl)--propan-2-one (14)
A mixture of 11a (2.78 g, 0.01 mol) and hydrazine hydrate (99-100%) (10 mL) was stirred in absolute ethanol (20 mL) for 2 hours. The reaction mixture was allowed to cool to room temperature, poured into cold water (100 mL) and neutralized by acetic acid. The deposited precipitate was collected by filtration, washed with water, dried and crystallized from dioxane.
PHARMACOLOGICAL SCREENING
Animals
Both sexes of Swiss albino mice (25-30 g) were used in analgesic activity testing and adult female Sprague-Dawley rats (150-180 g) were used in anti-inflammatory and ulcerogenic testing. International principle and local regulations concerning the care of used laboratory animals was taken into account (14) . The animals had free access to standard commercial diet and water ad libitum and were kept in rooms maintained at 22 ± 1°C with a 12 h light/dark cycle.
Anti-inflammatory activity
The method adopted resembles essentially that described by Winter et al. (15) . Tween--80 (10%, V/V) was selected as vehicle to suspend the standard drug and test compounds. The rats were starved for 18 h prior to the experiment. The animals were weighed, marked for identification and divided into 14 groups, each containing 6 animals. Edema was induced in the left hind paw of all rats by subcutaneous injection of 0.1 mL of 1% (m/V) aqueous carrageenean into their footpads. The 1 st group was kept as control and was given 1.0 mL of the vehicle. The 2 nd to 13 th groups were orally administered an aqueous suspension of the synthesized compounds (15 mg kg -1 body mass) 1 hour before carrageenean injection. The last group (standard) was administered indomethacin in a dose of 10 mg kg -1 body mass, orally as suspension in 10% Tween 80 (16) . The paw volume of each rat was measured with a mercury plethysmometer, before carrageenean injection and then hourly for 4 hours post administration of the suspension of synthesized compound in 10% Tween 80.
Analgesic activity
The compounds 4a-f, 5a,b, 6, 7 and 8a,b were selected for investigating their analgesic activity in acetic acid induced writhing response in mice, following the method of Collier et al. (17) . Eighty four mice were divided into 14 groups (six in each) and starved for 16 h. The 1 st group which served as control was orally given distilled water in an appropriate volume. The 2 nd to 13 th groups received the aqueous suspension of synthesized compounds orally (15 mg kg -1 body mass). The last group received acetylsalicylic acid orally in a dose of 100 mg kg -1 body mass. After 30 minutes, each mouse was administerated 0.7% of an aqueous solution of acetic acid (10 mL kg -1 body mass) and the mice were then placed in transparent boxes for observation. The number of writhes was counted for 20 min after acetic acid injection. The number of writhes in each treated group was compared to that of the control group. The number of writhings was recorded and the percentage protection was calculated.
Ulcerogenicity
Ulceration in rats was induced as described by Goel et al. (18) . Rats were divided into 14 groups, of six animals each. The control group of animals was administered only According to Gewald et al. (11) , heating under stirring of a mixture of ethylcyanoacetate, sulfur, benzylmethyl ketone and diethylamine in absolute ethanol for 8 hours afforded 2-amino-4-methyl-5-phenyl-thiophene-3-ethylcarboxylate 1 (85%). The latter compound was cyclized by refluxing in a mixture of potassium thiocyanate and dioxane in the presence of concentrated hydrochloric acid affording 5-methyl-6-phenyl-2-thioxo--thieno[2,3-d]pyrimidine derivative 2 (Scheme 1). The 1 H NMR spectrum of the resulting product 2 is in agreement with the given structure and literature (21) . Stirring a mixture of malononitrile, 6-methyl-heptane-2,4-dione, sulfur and diethylamine in absolute ethanol afforded acetone-1-(2-amino-5-isopropyl-thiophene-3-carbonitrile derivative 3 (73%) (Scheme 1). Also, the latter compound was used as a good source to enrich the synthesis of heterocyclic chemistry with several new thieno-pyrimidines, thienothiazine and thienopyridine derivatives.
As part of our continuing program on the synthesis of various functionalized mono--heterocyclic and annelated heterocyclic derivatives (22, 23) , we report here a new synthetic strategy for the preparation of functionalized thieno [2,3- 2-Amino-5-isopropyl-4-(2-oxo-propyl)-thiophene-3-carbonitrile (3) behaved as a typical b-enaminonitrile derivative due to the presence of amino and carbonitrile groups at positions 2 and 3, respectively, attached to the thiophene ring, which is considered as a precursor in the synthesis of various heterocyclic derivatives with several new azolothienopyrimidines, thienothiazine and thienopyrimidines (24) . Therefore, heating under reflux of compound 3 with aliphatic acids, namely, formic and acetic acids for 6 hours The anti-inflammatory activity data (Table III) indicated that all the test compounds protected rats from carrageenean induced inflammation. Compounds 4a, 4b, 4e, 5b, 6 and 7 protected rats by 36 to 56% from inflammation while the other tested compounds showed lower anti-inflamatory activity in comparison to indomethacin. This means that the fused triazolo [4,3- The results of analgesic activity indicate that all the test compounds exhibited high activity (Table IV) . Triazolo [4,3-a] pyrimidine 4a with triphenyl substitution showed high activity comparable to that of acetylsalicylic acid. The compounds with acetyl or ethylester group substitution (4b-d), showed moderate activity. Also, thieno [2,3-d] pyrimidines 5b and 6 and thieno [2,3-d] [1, 3] thiazin 7 were found to be the most active analgesic agents, even more potent than acetylsalicylic acid.
The ulcer index of the test compounds (Table V) reveals that all compounds showed a mild ulcer index as compared to acetylsalicylic acid. pyrimidin-4-one (5a) and compounds 5b, 6 and 7 showed good to excellent analgesic activity.
